Bhakuni, R., Hall, E. T., Gooley, T., Mowery, Y. M., Ansstas, G., Brohl, A. S., Burgess, M. A., Dimitrova, M., Gao, L., In, G. K., Ishizuka, J. J., Lutzky, J., Medina, T., Park, S. J., Saibil, S., Silk, A. W., Murray, J., Gore, S., Topalian, S. L., Nghiem, P. (2026). MATRiX: A randomized phase II trial of tuvusertib (ATR inhibitor) with or without avelumab in advanced anti-PD(L)-1 refractory Merkel cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba9514